Skip to main content
Top
Published in: Infection 3/2014

01-06-2014 | Clinical and Epidemiological Study

Recurrent pneumococcal invasive disease in the Region of Madrid during a five-year period

Authors: J. C. Sanz, I. Rodríguez-Avial, E. Ríos, B. Ramos, E. Cercenado

Published in: Infection | Issue 3/2014

Login to get access

Abstract

Purpose

The aim of this study was to describe the clinical and microbiological characteristics of recurrent invasive pneumococcal disease (RIPD) cases identified in the Region of Madrid between January 2007 and December 2011.

Methods

Streptococcus pneumoniae serotyping was performed by Pneumotest-Latex and Quellung reaction. Molecular typing was carried out by pulsed-field gel electrophoresis (PFGE). A relapse was defined as any case of RIPD caused by strains with similar PFGE profile. Re-infections were defined by detection of recurrent episodes caused by strains with different PFGE patterns.

Results

During the study period, 2,929 S. pneumoniae strains isolated from 2,858 patients with invasive pneumococcal disease (IPD) were studied. In 61 patients (2.1 %), 132 episodes of RIPD were detected (two episodes in 52 patients, three in 8 and four in 1). Twelve patients had relapses, 47 had re-infections and two had re-infections followed by relapses. Common risk factors to developing RIPD were HIV (42.6 %) and haematological malignancies (16.4 %). The most frequent serotypes were 8 (16 episodes) and 19A (15 episodes). Fourteen strains that were resistant to levofloxacin were also resistant to erythromycin. The proportion of strains co-resistant to erythromycin and levofloxacin was significantly higher in relapses (11/29) than in re-infections (3/103).

Conclusions

The occurrence of repeated episodes of IPD in the same patient over the time is not an exceptional issue. Some underlying conditions that may favour these recurrences, mainly immunosuppression, need to be considered in patients having an episode of IPD.
Appendix
Available only for authorised users
Literature
2.
go back to reference Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012–20.PubMedCentralPubMedCrossRef Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol. 2009;47:1012–20.PubMedCentralPubMedCrossRef
3.
go back to reference Mufson MA, Hao JB, Stanek RJ, Norton NB. Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease. Am J Med Sci. 2012;343:303–9.PubMedCrossRef Mufson MA, Hao JB, Stanek RJ, Norton NB. Clinical features of patients with recurrent invasive Streptococcus pneumoniae disease. Am J Med Sci. 2012;343:303–9.PubMedCrossRef
4.
go back to reference Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007;26:480–4.PubMedCrossRef Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J. 2007;26:480–4.PubMedCrossRef
5.
go back to reference Matsubara K, Fukaya T, Ubukata K, Chen M, Nigami H, Harigaya H, et al. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child. J Infect. 2007;54:e87–90.PubMedCrossRef Matsubara K, Fukaya T, Ubukata K, Chen M, Nigami H, Harigaya H, et al. Recurrence of occult pneumococcal bacteremia by an identical strain in an apparently healthy child. J Infect. 2007;54:e87–90.PubMedCrossRef
6.
go back to reference Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC, on behalf of the Madrid Streptococcus pneumoniae Microbiological Group (MSPSG). Clonal spread of levofloxacin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2007–2009). Antimicrob Agents Chemother. 2011;55:2469–71.PubMedCentralPubMedCrossRef Rodríguez-Avial I, Ramos B, Ríos E, Cercenado E, Ordobás M, Sanz JC, on behalf of the Madrid Streptococcus pneumoniae Microbiological Group (MSPSG). Clonal spread of levofloxacin-resistant Streptococcus pneumoniae invasive isolates in Madrid, Spain (2007–2009). Antimicrob Agents Chemother. 2011;55:2469–71.PubMedCentralPubMedCrossRef
7.
go back to reference Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV + patients. Clin Microbiol Infect. 2011;17:1094–8.PubMedCrossRef Sanz JC, Cercenado E, Marín M, Ramos B, Ardanuy C, Rodríguez-Avial I, et al. Multidrug-resistant pneumococci (serotype 8) causing invasive disease in HIV + patients. Clin Microbiol Infect. 2011;17:1094–8.PubMedCrossRef
8.
go back to reference CLSI performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008. CLSI performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. CLSI document M100-S18. Wayne: Clinical and Laboratory Standards Institute; 2008.
9.
go back to reference Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007. Clinical and Laboratory Standard Institute (CLSI). Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Wayne: Clinical and Laboratory Standards Institute; 2007.
10.
go back to reference McEllistrem MC, Stout JE, Harrison IH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol. 2000;38:351–3.PubMedCentralPubMed McEllistrem MC, Stout JE, Harrison IH. Simplified protocol for pulsed-field gel electrophoresis analysis of Streptococcus pneumoniae. J Clin Microbiol. 2000;38:351–3.PubMedCentralPubMed
11.
go back to reference Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strains typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strains typing. J Clin Microbiol. 1995;33:2233–9.PubMedCentralPubMed
12.
go back to reference King MD, Whitney CG, Parekh F, Farley MM. Active bacterial core surveillance team/emerging infections program network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029–36.PubMedCrossRef King MD, Whitney CG, Parekh F, Farley MM. Active bacterial core surveillance team/emerging infections program network. Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis. 2003;37:1029–36.PubMedCrossRef
13.
go back to reference Einarsdóttir HM, Erlendsdóttir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect. 2005;11:744–9.PubMedCrossRef Einarsdóttir HM, Erlendsdóttir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect. 2005;11:744–9.PubMedCrossRef
14.
go back to reference Antonio M, Oluwalana C, Secka O, Corrah T, Howie S, Adegbola RA. Exogenous re-infection by a novel Streptococcus pneumoniae serotype 14 as a cause of recurrent meningitis in a child from the Gambia. Ann Clin Microbiol Antimicrob. 2009;8:3.PubMedCentralPubMedCrossRef Antonio M, Oluwalana C, Secka O, Corrah T, Howie S, Adegbola RA. Exogenous re-infection by a novel Streptococcus pneumoniae serotype 14 as a cause of recurrent meningitis in a child from the Gambia. Ann Clin Microbiol Antimicrob. 2009;8:3.PubMedCentralPubMedCrossRef
15.
go back to reference Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.PubMedCrossRef Bogaert D, De Groot R, Hermans PW. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis. 2004;4:144–54.PubMedCrossRef
16.
go back to reference Rodríguez-Créixems M, Muñoz P, Miranda E, Peláez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med. 1996;156:1429–34.PubMedCrossRef Rodríguez-Créixems M, Muñoz P, Miranda E, Peláez T, Alonso R, Bouza E. Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med. 1996;156:1429–34.PubMedCrossRef
17.
go back to reference Font B, Llimiñana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:636–8.PubMed Font B, Llimiñana C, Fontanals D, Pineda V, Segura F. Eleven-year study of recurrent pneumococcal bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:636–8.PubMed
18.
go back to reference van Driel JJ, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988–2005. Clin Infect Dis. 2008;47:e42–51.PubMedCrossRef van Driel JJ, Bekker V, Spanjaard L, van der Ende A, Kuijpers TW. Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988–2005. Clin Infect Dis. 2008;47:e42–51.PubMedCrossRef
19.
go back to reference Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, et al. Toronto invasive bacterial diseases network. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One. 2009;4:e7255.PubMedCentralPubMedCrossRef Plevneshi A, Svoboda T, Armstrong I, Tyrrell GJ, Miranda A, Green K, et al. Toronto invasive bacterial diseases network. Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto. PLoS One. 2009;4:e7255.PubMedCentralPubMedCrossRef
20.
go back to reference Orlicek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr. 1997;130:284–8.PubMedCrossRef Orlicek SL, Herrod HG, Leggiadro RJ, Luedtke G, English BK. Repeated invasive pneumococcal infections in young children without apparent underlying immunodeficiency. J Pediatr. 1997;130:284–8.PubMedCrossRef
21.
go back to reference Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect. 2003;9:280–8.PubMedCrossRef Maugein J, Guillemot D, Dupont MJ, Fosse T, Laurans G, Roussel-Delvallez M, et al. Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia in eight French counties. Clin Microbiol Infect. 2003;9:280–8.PubMedCrossRef
22.
go back to reference Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004;190:2154–61.PubMedCrossRef Porat N, Arguedas A, Spratt BG, Trefler R, Brilla E, Loaiza C, et al. Emergence of penicillin-nonsusceptible Streptococcus pneumoniae clones expressing serotypes not present in the antipneumococcal conjugate vaccine. J Infect Dis. 2004;190:2154–61.PubMedCrossRef
23.
go back to reference Hunt Gerardo S, Citron DM, Goldstein EJ. PCR fingerprinting analysis for differentiation of Streptococcus pneumoniae reinfection versus relapse. Diagn Microbiol Infect Dis. 2000;36:275–8.PubMedCrossRef Hunt Gerardo S, Citron DM, Goldstein EJ. PCR fingerprinting analysis for differentiation of Streptococcus pneumoniae reinfection versus relapse. Diagn Microbiol Infect Dis. 2000;36:275–8.PubMedCrossRef
24.
go back to reference Gutierrez Rodríguez MA, Varela González A, Ordobás Gavín MA, Martín Martínez F, García Marína N, Ramos Blázquez B, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine. 2011;29:5740–6.CrossRef Gutierrez Rodríguez MA, Varela González A, Ordobás Gavín MA, Martín Martínez F, García Marína N, Ramos Blázquez B, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine. 2011;29:5740–6.CrossRef
25.
go back to reference Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 2009;64:507–10.PubMedCrossRef Ardanuy C, Rolo D, Fenoll A, Tarrago D, Calatayud L, Liñares J. Emergence of a multidrug-resistant clone (ST320) among invasive serotype 19A pneumococci in Spain. J Antimicrob Chemother. 2009;64:507–10.PubMedCrossRef
26.
go back to reference Ritchie ND, Mitchell TJ, Evans TJ. What is different about serotype 1 pneumococci? Future Microbiol. 2012;7:33–46.PubMedCrossRef Ritchie ND, Mitchell TJ, Evans TJ. What is different about serotype 1 pneumococci? Future Microbiol. 2012;7:33–46.PubMedCrossRef
27.
go back to reference Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM. Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination. Infection. 2013;41:663–8.PubMedCrossRef Munier AL, de Lastours V, Varon E, Donay JL, Porcher R, Molina JM. Invasive pneumococcal disease in HIV-infected adults in France from 2000 to 2011: antimicrobial susceptibility and implication of serotypes for vaccination. Infection. 2013;41:663–8.PubMedCrossRef
28.
go back to reference Isea-Peña MC, Sanz-Moreno JC, Esteban J, Fernández-Roblas R, Fernández-Guerrero ML. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection. 2013;41:935–9.PubMedCrossRef Isea-Peña MC, Sanz-Moreno JC, Esteban J, Fernández-Roblas R, Fernández-Guerrero ML. Risk factors and clinical significance of invasive infections caused by levofloxacin-resistant Streptococcus pneumoniae. Infection. 2013;41:935–9.PubMedCrossRef
29.
go back to reference Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, et al. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151–7.PubMedCrossRef Kang CI, Song JH, Kim SH, Chung DR, Peck KR, Thamlikitkul V, et al. Association of levofloxacin resistance with mortality in adult patients with invasive pneumococcal diseases: a post hoc analysis of a prospective cohort. Infection. 2013;41:151–7.PubMedCrossRef
30.
go back to reference Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR. 2012;61:394–5. Centers for Disease Control and Prevention (CDC). Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years and older. MMWR. 2012;61:394–5.
31.
go back to reference Vila-Corcoles A, Ochoa-Gondar O, Guzman-Avalos A, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, et al. Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002–2009. Infection. 2013;41:439–46.PubMedCrossRef Vila-Corcoles A, Ochoa-Gondar O, Guzman-Avalos A, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, et al. Incidence of pneumococcal infections among children under 15 years in southern Catalonia throughout the heptavalent conjugate vaccine era, 2002–2009. Infection. 2013;41:439–46.PubMedCrossRef
32.
go back to reference Schutze GE, Tucker NC, Mason EO Jr. Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease. Pediatr Infect Dis J. 2001;20:1009–10.PubMedCrossRef Schutze GE, Tucker NC, Mason EO Jr. Failure of the conjugate pneumococcal vaccine to prevent recurrent bacteremia in a child with human immunodeficiency virus disease. Pediatr Infect Dis J. 2001;20:1009–10.PubMedCrossRef
33.
go back to reference Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8:1–13.CrossRef Nunes MC, Madhi SA. Safety, immunogenicity and efficacy of pneumococcal conjugate vaccine in HIV-infected individuals. Hum Vaccin Immunother. 2012;8:1–13.CrossRef
34.
go back to reference American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126:186–90.CrossRef American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126:186–90.CrossRef
35.
go back to reference Picazo JJ, González-Romo F, García Rojas A, Pérez-Trallero E, Gil Gregorio P, de la Cámara R, et al. Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base. Rev Esp Quimioter. 2013;26:232–52.PubMed Picazo JJ, González-Romo F, García Rojas A, Pérez-Trallero E, Gil Gregorio P, de la Cámara R, et al. Consenso sobre la vacunación anti-neumocócica en el adulto con patología de base. Rev Esp Quimioter. 2013;26:232–52.PubMed
Metadata
Title
Recurrent pneumococcal invasive disease in the Region of Madrid during a five-year period
Authors
J. C. Sanz
I. Rodríguez-Avial
E. Ríos
B. Ramos
E. Cercenado
Publication date
01-06-2014
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 3/2014
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-013-0571-3

Other articles of this Issue 3/2014

Infection 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.